Connor, Clark & Lunn Investment Management (CC&L)
COLL icon

Connor, Clark & Lunn Investment Management (CC&L)’s Collegium Pharmaceutical COLL Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,825
Closed -$2.54M – 1577
2025
Q4 		$2.54M Sell
54,825
-100,265
-65% -$4.19M 0.01% 855
2025
Q3 		$5.43M Sell
155,090
-2,004
-1% -$69.7K 0.02% 558
2025
Q2 		$4.65M Buy
157,094
+53,735
+52% +$1.53M 0.02% 594
2025
Q1 		$3.09M Buy
+103,359
New +$3.16M 0.01% 615
2024
Q2 		– Sell
-8,573
Closed -$333K – 1428
2024
Q1 		$333K Sell
8,573
-29,818
-78% -$1.04M ﹤0.01% 1230
2023
Q4 		$1.18M Sell
38,391
-44,151
-53% -$1.11M 0.01% 816
2023
Q3 		$1.84M Buy
82,542
+4,046
+5% +$92.3K 0.01% 642
2023
Q2 		$1.69M Buy
78,496
+36,799
+88% +$835K 0.01% 652
2023
Q1 		$1M Buy
+41,697
New +$1.11M 0.01% 713
2022
Q2 		– Sell
-18,882
Closed -$384K – 1066
2022
Q1 		$384K Buy
+18,882
New +$357K ﹤0.01% 830
2019
Q3 		– Sell
-10,400
Closed -$137K – 972
2019
Q2 		$137K Buy
+10,400
New +$139K ﹤0.01% 936

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s COLL Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 54,825 shares — an estimated $2.54M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in COLL in Q2 2019 and held it in 11 quarters. The position peaked at $5.43M in Q3 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 54,825 Collegium Pharmaceutical shares in Q1 2026, an estimated $2.54M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Collegium Pharmaceutical position peaked at $5.43M in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.